Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture - Wikidata - wikimedia - TriplyDB

Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture

Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture

http://www.wikidata.org/entity/Q28361902

about

Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy Absence of rapid selection for acyclovir or penciclovir resistance following suboptimal oral prodrug therapy of HSV-infected mice Famciclovir for treatment of herpesvirus infections In vitro activities of penciclovir and acyclovir against herpes simplex virus types 1 and 2 Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus Mode of action of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cells Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir]Activities of two new antiviral agents against guinea pig lymphotropic herpesvirus infection in vitro Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxymethylbut-1-yl) guanine (BRL 39123) in animals Activity of penciclovir against Epstein-Barr virus Mode of action of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl) cycloprop-1'-yl]methyl]guanine (A-5021) against herpes simplex virus type 1 and type 2 and varicella-zoster virus.Evaluation of a novel, anti-herpes simplex virus compound, acyclovir elaidate (P-4010), in the female guinea pig model of genital herpes Antiherpesvirus activities of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]guanine (A-5021) in cell culture Famciclovir and valaciclovir differ in the prevention of herpes simplex virus type 1 latency in mice: a quantitative study.Determination of penciclovir in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a clinical pharmacokinetic study.Intravenous penciclovir for treatment of herpes simplex infections in immunocompromised patients: results of a multicenter, acyclovir-controlled trial. The Penciclovir Immunocompromised Study Group.Emerging drugs for varicella-zoster virus infections.Novel agents for the therapy of varicella-zoster virus infections.Susceptibilities of herpes simplex viruses to penciclovir and acyclovir in eight cell lines.9-[4-Hydr-oxy-3-(hydroxy-meth-yl)but-yl]guanine monohydrate Activity and mechanism of action of N-methanocarbathymidine against herpesvirus and orthopoxvirus infections.The tolerance to and pharmacokinetics of penciclovir (BRL 39,123A), a novel antiherpes agent, administered by intravenous infusion to healthy subjects.Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy Comparative activity of penciclovir and acyclovir in mice infected intraperitoneally with herpes simplex virus type 1 SC16.A review of famciclovir in the management of genital herpes.Effects of probenecid on the pharmacokinetics of allopurinol riboside.New antiviral agents.Famciclovir: a review of its use in herpes zoster and genital and orolabial herpes.Single-day treatment for orolabial and genital herpes: a brief review of pathogenesis and pharmacology A review of antiviral drugs and other compounds with activity against feline herpesvirus type 1 Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile (2nd edition): DNA viruses.Management of genital herpes simplex infection.The resurgence of acyclic nucleic acids.5-azacytosine compounds in medicinal chemistry: current stage and future perspectives.Difference in incidence of spontaneous mutations between Herpes simplex virus types 1 and 2.Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir.Synthesis of novel 6-azapyrimidine acyclic nucleoside analogues and antiviral evaluation.In vitro activity of penciclovir against clinical isolates of acyclovir-resistant and foscarnet-resistant herpes simplex virus.Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS.Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile (2nd edition): retroviruses and hepadnaviruses.

P2860

Q24672068-0EBC76B5-76AD-4B11-9C37-CDFF7E4FA11B Q24797196-E11DE36F-4162-4924-AA43-280DEA73E5B8 Q28293932-129E2C46-547B-45D7-ABE1-ECE97ECA7915 Q28326891-34F7329F-7836-4418-ABC7-095632B8FB17 Q28327167-D1FCC5B2-2234-4CAE-8AE1-B801451D672D Q28342540-B8EDE62D-3320-4E46-8764-FC8FD9FCD901 Q28354274-D6D42013-1508-4D15-BCD4-836C9DCBDB1C Q28359733-D5BF0DA6-D828-45D2-BE81-37D1D0029C39 Q28361450-AA446783-A112-4225-8123-CEFBB31324F5 Q28367461-99CFD752-65B5-4922-942E-C0F49AD8BB24 Q28368325-6B563FD9-4C4B-4589-A8F4-AC71A532775E Q28369457-FFD795AC-58B7-4523-94D6-C64D285819AB Q28379618-DA3E75F2-011A-4D62-920C-A61557D65709 Q33693860-DE7CB9DE-2652-4899-B509-621B434FAAEF Q33837094-3237BA2D-94CE-4409-9707-EBD8BA33ED54 Q33976296-1A0377EF-52E2-464C-A941-EA2BA3879EE7 Q34027426-5FB2C529-74C6-4230-A364-90869552DEB6 Q34074994-177DE24A-4473-4EBE-B22F-07DB1506E1CC Q34113580-BF827C90-E172-47D4-931F-2829192C4BAD Q34270723-5B3B31D3-814F-48FB-8C31-D7F350E62223 Q34510424-6A24F569-7E48-4BD0-808F-224D9608CAD1 Q34538195-6FDE09AC-8A19-4F3B-9D5B-79EC275B973B Q34579981-872405A4-C0E3-4AB0-A3ED-D29A998320D9 Q34729783-7351B85C-FC12-4A31-94DD-7AC3A1209CF1 Q35615364-D39978C4-01B9-488E-AF02-66A13FA0F39B Q35815511-892CB71C-38AD-41C5-AE9E-5156E3E7CD68 Q36525651-9DCF9294-978B-4328-82D6-C2BF55FBD962 Q36688916-60C3F911-27DB-45EB-9605-CF881CA47F62 Q36823598-19D9C9C5-7025-4C27-A76F-6920CC24192E Q37059841-0AB10878-AB45-436E-8676-2D6874BAA771 Q37252268-5E03E792-9B2B-4A52-A832-E6B3F04D030D Q37545127-1E0D6CF8-3D7C-438B-AC6B-DB99E5B76F66 Q37691376-CE417A8C-401E-4CCE-95ED-41E2B9EFC8A0 Q38014898-0A33A0C6-3E70-4DA8-B6B0-F8F6ADEF0D64 Q39474039-9D71266A-9CDB-40BB-926A-D187F00EA259 Q39602136-B987F252-EA43-4A03-B686-5F663D623607 Q39686917-F99FDD68-B2D3-43B3-83C0-E4CBC220CDE6 Q39882007-02E044DA-9B69-4796-8917-902F1D05DC48 Q40044028-171C5A88-1054-4562-A840-C95397D77EFB Q40055204-C3B76CB3-22C5-46BA-87D3-A6D56BCAE7B0

P2860

Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture

http://www.wikidata.org/entity/Q28361902

description

1987 nî lūn-bûn

@nan

1987 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1987 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1987年の論文

@ja

1987年論文

@yue

1987年論文

@zh-hant

1987年論文

@zh-hk

1987年論文

@zh-mo

1987年論文

@zh-tw

1987年论文

@wuu

name

Antiherpesvirus activity of 9- ...... ne (BRL 39123) in cell culture

@ast

Antiherpesvirus activity of 9- ...... ne (BRL 39123) in cell culture

@en

Antiherpesvirus activity of 9- ...... ne (BRL 39123) in cell culture

@nl

type

label

Antiherpesvirus activity of 9- ...... ne (BRL 39123) in cell culture

@ast

Antiherpesvirus activity of 9- ...... ne (BRL 39123) in cell culture

@en

Antiherpesvirus activity of 9- ...... ne (BRL 39123) in cell culture

@nl

prefLabel

Antiherpesvirus activity of 9- ...... ne (BRL 39123) in cell culture

@ast

Antiherpesvirus activity of 9- ...... ne (BRL 39123) in cell culture

@en

Antiherpesvirus activity of 9- ...... ne (BRL 39123) in cell culture

@nl

P1433

Q28361902-806520C9-49E3-454C-B674-DA9CF00E2764

P1476

Q28361902-40300493-BAF3-4090-9F27-9B6A9CBE7F32

P2093

Q28361902-3B3F4CB0-1A9D-49A6-BB9D-DBADAE12AD83

Q28361902-56B5F788-916B-4DB2-AD07-7724FFEF0DEC

Q28361902-67C669DC-7BFA-411E-B903-C9DABC824E63

Q28361902-FEEA2D0C-91BB-4658-BF2D-91732B6036C7

P2860

Q28361902-01385D53-C6F4-459F-A8B6-4CAB5895A0F0

Q28361902-0F672D3F-52FA-4F9F-A37F-E009A99AA38F

Q28361902-1D78C39B-286F-43D6-9EEC-561379E7A685

Q28361902-1FBD35D2-F11A-46F1-AD54-2B9F0FE2A56B

Q28361902-2DCEF457-3A6C-4A36-8955-4B4D05F79DAA

Q28361902-337677BD-8F3D-4A5C-B4E0-4A0B62838B43

Q28361902-4AC2571E-688B-4614-B925-71A3A63887DA

Q28361902-4C2513D6-7A7C-4976-BD77-BEE76B9D86ED

Q28361902-4CFDB8E3-59F5-4E65-82B2-99A6A1C421C0

Q28361902-4D320010-50F5-4EFA-9F98-35ADCF8087A4

P304

Q28361902-7139A8E9-271F-4162-885A-DA8347963E40

P31

Q28361902-C3615EDB-19EC-454A-B638-6C8FF12FE50C

P356

Q28361902-91F53742-86A3-4D12-A910-8EBF5FE7FDA3

P407

Q28361902-27B64545-17A9-40B3-9CC9-32CD68AA00EB

P433

Q28361902-CDB5B653-9C7F-4E26-B353-9192DC118E33

P478

Q28361902-7746C9C7-70C3-456E-A86F-AB80F267B61B

P577

Q28361902-206492D3-C316-43C7-A7EA-795E6F2DE5F7

P698

Q28361902-7F763E59-0041-4B9E-9B67-1098D11DDA93

P932

Q28361902-C03C6CA2-DD19-4153-8B29-418D18EA276F

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Antiherpesvirus activity of 9- ...... ne (BRL 39123) in cell culture

@en

P2093

D Sutton

http://www.w3.org/2001/XMLSchema#string

M Cole

http://www.w3.org/2001/XMLSchema#string

M R Boyd

http://www.w3.org/2001/XMLSchema#string

T H Bacon

http://www.w3.org/2001/XMLSchema#string

P2860

Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine

9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group

Mode of action, toxicity, pharmacokinetics, and efficacy of some new antiherpesvirus guanosine analogs related to buciclovir

In vitro susceptibility of varicella-zoster virus to acyclovir

A new nucleoside analog, 9-[[2-hydroxy-1-(hydroxymethyl)ethoxyl]methyl]guanine, highly active in vitro against herpes simplex virus types 1 and 2

Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1

9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication

9-(3,4-dihydroxybutyl)guanine, a new inhibitor of herpesvirus multiplication

Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine

Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication

P304

1238-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.31.8.1238

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

1987-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

3631945

http://www.w3.org/2001/XMLSchema#string

P932

174911

http://www.w3.org/2001/XMLSchema#string